Works by Azizi, Amedeo

Results: 49
    1

    A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes.

    Published in:
    Human Mutation, 2019, v. 40, n. 5, p. 649, doi. 10.1002/humu.23721
    By:
    • Gallon, Richard;
    • Mühlegger, Barbara;
    • Wenzel, Sören‐Sebastian;
    • Sheth, Harsh;
    • Hayes, Christine;
    • Aretz, Stefan;
    • Dahan, Karin;
    • Foulkes, William;
    • Kratz, Christian P.;
    • Ripperger, Tim;
    • Azizi, Amedeo A.;
    • Baris Feldman, Hagit;
    • Chong, Anne‐Laure;
    • Demirsoy, Ugur;
    • Florkin, Benoît;
    • Imschweiler, Thomas;
    • Januszkiewicz‐Lewandowska, Danuta;
    • Lobitz, Stephan;
    • Nathrath, Michaela;
    • Pander, Hans‐Jürgen
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.

    Published in:
    Neuro-Oncology Practice, 2024, v. 11, n. 4, p. 395, doi. 10.1093/nop/npae001
    By:
    • Dhaenens, Britt A E;
    • Heimann, Günter;
    • Bakker, Annette;
    • Nievo, Marco;
    • Ferner, Rosalie E;
    • Evans, D Gareth;
    • Wolkenstein, Pierre;
    • Leubner, Jonas;
    • Potratz, Cornelia;
    • Carton, Charlotte;
    • Iloeje, Uchenna;
    • Kirk, George;
    • Blakeley, Jaishri O;
    • Plotkin, Scott;
    • Fisher, Michael J;
    • Kim, AeRang;
    • Driever, Pablo Hernáiz;
    • Azizi, Amedeo A;
    • Widemann, Brigitte C;
    • Gross, Andrea
    Publication type:
    Article
    8
    9
    10
    11
    12

    Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.

    Published in:
    International Journal of Clinical Pharmacology & Therapeutics, 2014, v. 52, n. 1, p. 76, doi. 10.5414/CPXCES13EA02
    By:
    • Buchroithner, Johanna;
    • Pichler, Josef;
    • Marosi, Christine;
    • Widhalm, Georg;
    • Seiz-Rosenhagen, Marcel;
    • Novosielski, Martha;
    • Oberndorfer, Stefan;
    • Ruckser, Reinhard;
    • Rössler, Karl;
    • Azizi, Amedeo;
    • von Campe, Gord;
    • Bordihn, Karin;
    • Felzmann, Thomas
    Publication type:
    Article
    13
    14
    15
    16

    Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1401761
    By:
    • Hedrich, Cora;
    • Patel, Priya;
    • Haider, Lukas;
    • Taylor, Tracey;
    • Lau, Elaine;
    • Hook, Roxanne;
    • Dorfer, Christian;
    • Roessler, Karl;
    • Stepien, Natalia;
    • Lippolis, Maria Aliotti;
    • Schned, Hannah;
    • Koeller, Clara;
    • Mayr, Lisa;
    • Azizi, Amedeo A.;
    • Peyrl, Andreas;
    • Lopez, Bienvenido Ros;
    • Lassaletta, Alvaro;
    • Bennett, Julie;
    • Gojo, Johannes;
    • Bartels, Ute
    Publication type:
    Article
    17

    No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency.

    Published in:
    Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01506
    By:
    • Tesch, Victoria K.;
    • IJspeert, Hanna;
    • Raicht, Andrea;
    • Rueda, Daniel;
    • Dominguez-Pinilla, Nerea;
    • Allende, Luis M.;
    • Colas, Chrystelle;
    • Rosenbaum, Thorsten;
    • Ilencikova, Denisa;
    • Baris, Hagit N.;
    • Nathrath, Michaela H. M.;
    • Suerink, Manon;
    • Januszkiewicz-Lewandowska, Danuta;
    • Ragab, Iman;
    • Azizi, Amedeo A.;
    • Wenzel, Soeren S.;
    • Zschocke, Johannes;
    • Schwinger, Wolfgang;
    • Kloor, Matthias;
    • Blattmann, Claudia
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities.

    Published in:
    Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01436
    By:
    • Gojo, Johannes;
    • Pavelka, Zdenek;
    • Zapletalova, Danica;
    • Schmook, Maria T.;
    • Mayr, Lisa;
    • Madlener, Sibylle;
    • Kyr, Michal;
    • Vejmelkova, Klara;
    • Smrcka, Martin;
    • Czech, Thomas;
    • Dorfer, Christian;
    • Skotakova, Jarmila;
    • Azizi, Amedeo A.;
    • Chocholous, Monika;
    • Reisinger, Dominik;
    • Lastovicka, David;
    • Valik, Dalibor;
    • Haberler, Christine;
    • Peyrl, Andreas;
    • Noskova, Hana
    Publication type:
    Article
    29

    Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC -Amplified Group 3 Medulloblastoma by Droplet Digital PCR.

    Published in:
    Cancers, 2023, v. 15, n. 9, p. 2525, doi. 10.3390/cancers15092525
    By:
    • Stepien, Natalia;
    • Senfter, Daniel;
    • Furtner, Julia;
    • Haberler, Christine;
    • Dorfer, Christian;
    • Czech, Thomas;
    • Lötsch-Gojo, Daniela;
    • Mayr, Lisa;
    • Hedrich, Cora;
    • Baumgartner, Alicia;
    • Aliotti-Lippolis, Maria;
    • Schned, Hannah;
    • Holler, Johannes;
    • Bruckner, Katharina;
    • Slavc, Irene;
    • Azizi, Amedeo A.;
    • Peyrl, Andreas;
    • Müllauer, Leonhard;
    • Madlener, Sibylle;
    • Gojo, Johannes
    Publication type:
    Article
    30

    Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.

    Published in:
    Cancers, 2022, v. 14, n. 20, p. 5128, doi. 10.3390/cancers14205128
    By:
    • Slavc, Irene;
    • Mayr, Lisa;
    • Stepien, Natalia;
    • Gojo, Johannes;
    • Aliotti Lippolis, Maria;
    • Azizi, Amedeo A.;
    • Chocholous, Monika;
    • Baumgartner, Alicia;
    • Hedrich, Cora S.;
    • Holm, Stefan;
    • Sehested, Astrid;
    • Leblond, Pierre;
    • Dieckmann, Karin;
    • Haberler, Christine;
    • Czech, Thomas;
    • Kool, Marcel;
    • Peyrl, Andreas
    Publication type:
    Article
    31
    32

    LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.

    Published in:
    BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11820-x
    By:
    • van Tilburg, Cornelis M.;
    • Kilburn, Lindsay B.;
    • Perreault, Sébastien;
    • Schmidt, Rene;
    • Azizi, Amedeo A.;
    • Cruz-Martínez, Ofelia;
    • Zápotocký, Michal;
    • Scheinemann, Katrin;
    • Meeteren, Antoinette Y. N. Schouten-van;
    • Sehested, Astrid;
    • Opocher, Enrico;
    • Driever, Pablo Hernáiz;
    • Avula, Shivaram;
    • Ziegler, David S.;
    • Capper, David;
    • Koch, Arend;
    • Sahm, Felix;
    • Qiu, Jiaheng;
    • Tsao, Li-Pen;
    • Blackman, Samuel C.
    Publication type:
    Article
    33

    Initial Evidence for Positive Effects of a Psychological Preparation Program for MRI "iMReady" in Children with Neurofibromatosis Type I and Brain Tumors—How to Meet the Patients' Needs Best.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1902, doi. 10.3390/jcm12051902
    By:
    • Weiler-Wichtl, Liesa Josephine;
    • Fries, Jonathan;
    • Fohn-Erhold, Verena;
    • Schwarzinger, Agathe;
    • Holzer, Angelika Elisabeth;
    • Pletschko, Thomas;
    • Furtner-Srajer, Julia;
    • Prayer, Daniela;
    • Bär, Paul;
    • Slavc, Irene;
    • Peyrl, Andreas;
    • Azizi, Amedeo;
    • Hansl, Rita;
    • Leiss, Ulrike
    Publication type:
    Article
    34
    35
    36

    Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma.

    Published in:
    Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 1, doi. 10.3390/jpm10040290
    By:
    • Mayr, Lisa;
    • Guntner, Armin S.;
    • Madlener, Sibylle;
    • Schmook, Maria T.;
    • Peyrl, Andreas;
    • Azizi, Amedeo A.;
    • Dieckmann, Karin;
    • Reisinger, Dominik;
    • Stepien, Natalia M.;
    • Schramm, Kathrin;
    • Laemmerer, Anna;
    • Jones, David T. W.;
    • Ecker, Jonas;
    • Sahm, Felix;
    • Milde, Till;
    • Pajtler, Kristian W.;
    • Blattner-Johnson, Mirjam;
    • Strbac, Miroslav;
    • Dorfer, Christian;
    • Czech, Thomas
    Publication type:
    Article
    37
    38
    39

    Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method.

    Published in:
    Acta Neuropathologica, 2025, v. 149, n. 1, p. 1, doi. 10.1007/s00401-024-02842-7
    By:
    • Madlener, Sibylle;
    • Stepien, Natalia;
    • Senfter, Daniel;
    • Mayr, Lisa;
    • Laemmerer, Anna;
    • Hedrich, Cora;
    • Baumgartner, Alicia;
    • Lötsch-Gojo, Daniela;
    • Sterba, Jaroslav;
    • Pokorna, Petra;
    • Kiesel, Barbara;
    • Widhalm, Georg;
    • Eckert, Franziska;
    • Preusser, Matthias;
    • Rössler, Karl;
    • Azizi, Amedeo;
    • Peyrl, Andreas;
    • Czech, Thomas;
    • Haberler, Christine;
    • Slavc, Irene
    Publication type:
    Article
    40

    Clinical applicability of miR517a detection in liquid biopsies of ETMR patients.

    Published in:
    Acta Neuropathologica, 2023, v. 145, n. 6, p. 843, doi. 10.1007/s00401-023-02567-z
    By:
    • Madlener, Sibylle;
    • Furtner, Julia;
    • Stepien, Natalia;
    • Senfter, Daniel;
    • Mayr, Lisa;
    • Zeyda, Maximilian;
    • Gramss, Leon;
    • Aistleitner, Barbara;
    • Spiegl-Kreinecker, Sabine;
    • Rivelles, Elisa;
    • Dorfer, Christian;
    • Rössler, Karl;
    • Czech, Thomas;
    • Azizi, Amedeo A.;
    • Peyrl, Andreas;
    • Lötsch-Gojo, Daniela;
    • Müllauer, Leonhard;
    • Haberler, Christine;
    • Slavc, Irene;
    • Gojo, Johannes
    Publication type:
    Article
    41

    TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF<sup>V600E</sup>/TERT promoter double-mutated glioma.

    Published in:
    Acta Neuropathologica Communications, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40478-019-0775-6
    By:
    • Gabler, Lisa;
    • Lötsch, Daniela;
    • Kirchhofer, Dominik;
    • van Schoonhoven, Sushilla;
    • Schmidt, Hannah M.;
    • Mayr, Lisa;
    • Pirker, Christine;
    • Neumayer, Katharina;
    • Dinhof, Carina;
    • Kastler, Lucia;
    • Azizi, Amedeo A.;
    • Dorfer, Christian;
    • Czech, Thomas;
    • Haberler, Christine;
    • Peyrl, Andreas;
    • Kumar, Rajiv;
    • Slavc, Irene;
    • Spiegl-Kreinecker, Sabine;
    • Gojo, Johannes;
    • Berger, Walter
    Publication type:
    Article
    42

    Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 8, p. 1357, doi. 10.1093/neuonc/noae074
    By:
    • O'Hare, Patricia;
    • Cooney, Tabitha;
    • Blank, Peter de;
    • Gutmann, David H;
    • Kieran, Mark;
    • Milde, Till;
    • Fangusaro, Jason;
    • Fisher, Michael;
    • Avula, Shivaram;
    • Packer, Roger;
    • Fukuoka, Kohei;
    • Mankad, Kshitij;
    • Mueller, Sabine;
    • Waanders, Angela J;
    • Opocher, Enrico;
    • Bouffet, Eric;
    • Raabe, Eric;
    • Werle, Natacha Entz;
    • Azizi, Amedeo A;
    • Robison, Nathan J
    Publication type:
    Article
    43

    LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 11, p. 2087, doi. 10.1093/neuonc/noad078
    By:
    • Hardin, Emily C;
    • Schmid, Simone;
    • Sommerkamp, Alexander;
    • Bodden, Carina;
    • Heipertz, Anna-Elisa;
    • Sievers, Philipp;
    • Wittmann, Andrea;
    • Milde, Till;
    • Pfister, Stefan M;
    • Deimling, Andreas von;
    • Horn, Svea;
    • Herz, Nina A;
    • Simon, Michèle;
    • Perera, Ashwyn A;
    • Azizi, Amedeo;
    • Cruz, Ofelia;
    • Curry, Sarah;
    • Damme, An Van;
    • Garami, Miklos;
    • Hargrave, Darren
    Publication type:
    Article
    44
    45
    46

    Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 9, p. 1183, doi. 10.1093/neuonc/nox027
    By:
    • Gojo, Johannes;
    • Lötsch, Daniela;
    • Spiegl-Kreinecker, Sabine;
    • Pajtler, Kristian W.;
    • Neumayer, Katharina;
    • Korbel, Pia;
    • Araki, Asuka;
    • Brandstetter, Anita;
    • Mohr, Thomas;
    • Hovestadt, Volker;
    • Chavez, Lukas;
    • Kirchhofer, Dominik;
    • Ricken, Gerda;
    • Stefanits, Harald;
    • Korshunov, Andrey;
    • Pfister, Stefan M.;
    • Dieckmann, Karin;
    • Azizi, Amedeo A.;
    • Czech, Thomas;
    • Filipits, Martin
    Publication type:
    Article
    47
    48
    49